Axogen (AXGN) Gross Profit Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.30% |
| Dec 31, 2025 | 10.44% |
| Sep 30, 2025 | 10.65% |
| Jun 30, 2025 | 20.54% |
| Mar 31, 2025 | 12.43% |
| Dec 31, 2024 | 10.05% |
| Sep 30, 2024 | 8.66% |
| Jun 30, 2024 | 9.50% |
| Mar 31, 2024 | 10.76% |
| Dec 31, 2023 | 10.10% |
| Sep 30, 2023 | 10.56% |
| Jun 30, 2023 | 11.15% |
| Mar 31, 2023 | 14.39% |
| Dec 31, 2022 | 11.19% |
| Sep 30, 2022 | 17.85% |
| Jun 30, 2022 | 16.92% |
| Mar 31, 2022 | 19.78% |
| Dec 31, 2021 | 22.21% |
| Sep 30, 2021 | 22.25% |
| Jun 30, 2021 | 24.52% |
| Mar 31, 2021 | 30.99% |
| Dec 31, 2020 | 33.42% |
| Sep 30, 2020 | 32.68% |
| Jun 30, 2020 | 25.15% |
| Mar 31, 2020 | 37.42% |
| Dec 31, 2019 | 43.42% |
| Sep 30, 2019 | 44.83% |
| Jun 30, 2019 | 46.51% |
| Mar 31, 2019 | 51.69% |
| Dec 31, 2018 | 52.64% |
| Sep 30, 2018 | 52.76% |
| Jun 30, 2018 | 50.97% |
| Mar 31, 2018 | 55.84% |
| Dec 31, 2017 | 55.75% |
| Sep 30, 2017 | 56.58% |
| Jun 30, 2017 | 53.54% |
| Mar 31, 2017 | 53.43% |
| Dec 31, 2016 | 63.16% |
| Sep 30, 2016 | 290.76% |
| Jun 30, 2016 | 61.67% |
| Mar 31, 2016 | 53.66% |
| Dec 31, 2015 | 185.41% |
| Sep 30, 2015 | 60.16% |